Ayala Pharmaceuticals Inc (ADXS): Down $5.50 (33%) from the post AMGEN dea...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	8
Posts	3089
Boards Moderated	0
Alias Born	08/09/2016

Batermere

Re: None

Friday, 09/23/2016 8:40:50 PM

Friday, September 23, 2016 8:40:50 PM

Down $5.50 (33%) from the post AMGEN deal high. Ouch. Am I worried ? No, not in the least bit. I think more deals will be struck with other BPs with our various pipelines in the next 6 months and we will look back at $10.80 and laugh. The thing that keeps me positive are the clinical results. Everything has been positive. The ONLY negative event/outcome was the FDA clinical hold after the patient death during the Cervical Cancer clinical trial and we all know now how and why that happened. The future is as bright as it ever has been and that includes when we hit $30 over a year ago. That stock price was never going to be sustainable at that level going forward. The nice slow steady climb with a few spikes up
and down along the way is fine with me. It's ADXS for crying out loud. It's a rollercoaster ride and always has been. Have a great weekend everyone.